Navigation Links
Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting

nalog). This provides an early indication that ProLindac can effectively substitute for oxaliplatin in combination therapies. While this study shows that ProLindac and oxaliplatin have similar cytotoxicities on an equimolar basis, in vivo studies reported elsewhere demonstrate that much higher doses of ProLindac can be administered compared to oxaliplatin. Therefore, based on the data presented here, ProLindac has potential for superior efficacy in vivo. This work was conducted primarily at the Department of Medical Oncology, Hospital Beaujon, Clichy, France.

The second poster is entitled "Preclinical study of the transport and intracellular distribution of ProLindac, a novel diaminocyclohexane-platinum (DACH-Pt) tumor-targeting drug delivery system." This poster describes studies which examine the transportation and distribution of ProLindac in human cancer cell lines and the rate of formation of -platinum-DNA-adducts. It is the formation of such adducts which appears to be a major contributor to the anticancer activity of platinum drugs. High levels of these adducts are formed when tumor cells are exposed to ProLindac. Incubation of tumor cells with ProLindac resulted in an increase in G2/M phase and apoptosis in human cancer cell lines. Both of these effects are associated with antitumor activity. Intracellular concentrations of platinum in HCT-116 tumor cells were about 10-fold greater when the incubating medium pH was lowered from 7.0 to 5.4. Previously Access had shown a faster release of platinum as pH is lowered in a simple aqueous system. This study confirms that tumor cell uptake of platinum from ProLindac is enhanced as pH is lowered; lowered pH is typically seen in hypoxic tumors. This work was conducted primarily at the Rene Huguenin Cancer Center, Saint-Cloud, France.

About ProLindac(TM)

Access' lead compound, ProLindac(TM), is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both
'"/>




Page: 1 2 3 4

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex ... it expects to report results for the fourth quarter ... release announcing the results is scheduled for release after ... http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will hold a conference ... for the fourth quarter and twelve months ended December ...
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new ... targeting guide with accompanying instrumentation to place and insert ... to the soft tissue (e.g. ligament) repair or reconstruction ... repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ... the anatomical reduction (spacing) of the scaphoid and lunate ...
(Date:1/14/2014)... 2014   Oligomerix, Inc. , a privately ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... headquarters to Valhalla, NY ... agreement for additional laboratory space at New York ... on the development of small molecule drugs aimed ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Prime Therapeutics (Prime), a leading pharmacy benefit manager, ... chief financial officer (CFO). DuCharme will lead Prime,s finance ... growth. "Jim brings deep health plan expertise ... within diverse health plans, including Blue Cross and Blue ...
... 2012  The hospitality industry is expecting a busy summer ... over the Memorial Day weekend, more hotels and resorts ... satisfaction of customers, according George Clarke, CEO of UMF ... "We,re seeing more hotels and resorts adopting environmental hygiene ...
Cached Medicine Technology:With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... 1 More than 125 leaders,from throughout the ... joined,together to support a multi-year, statewide campaign to ... campaign, launched by Nemours Health,and Prevention Services (NHPS), ... health professionals, parents, and other leaders to,improve the ...
... Team will develop "probes" to aid in the ... 1 Southern Research,Institute --- a not-for-profit organization ... of preclinical drug discovery and drug development --,today ... Institute of,Mental Health (NIMH) to identify small molecules ...
... GARDNER, Mass., Oct. 1 Precision Optics,Corporation, Inc. (OTC ... the fourth quarter and fiscal year ended,June 30, 2007. ... the quarter ended June 30, 2007, revenues were,$1,111,833 compared ... increase,of 94%. This represents the highest quarterly revenue in ...
... Oct. 1 Mylan Laboratories Inc.,(NYSE: MYL ) ... Vice,President and Treasurer, effective October 22, 2007. Mr. Byala ... with responsibility for,treasury planning in both New York and ... in various treasury positions of increasing responsibility.,Prior to Pfizer, ...
... Oct. 1 A healthy diet and,good nutrition are ... The Pennsylvania Dental Association (PDA) stresses the,importance of watching ... Think of your body as a complex machine. The ... up" affect your general health and that of your,teeth ...
... 1 Bally Total Fitness announced,that it has ... private company,just over two months after filing for ... funded by Harbinger Capital Partners,Master Fund I, Ltd. ... became effective today. Harbinger invested approximately $233.6 ...
Cached Medicine News:Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Southern Research Institute's Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding 2Health News:Southern Research Institute's Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding 3Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 2Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 3Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 4Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 5Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 6Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 7Health News:Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years 8Health News:Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer 2Health News:PDA Stresses Importance of Good Nutrition 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: